Ena Respiratory
Ena Respiratory is a biotechnology company seeking to transform the treatment and prevention of respiratory infections and the effectiveness of vaccines. Ena Respiratory novel, synthetic Toll-like receptor 2 (TLR2) receptor agonists have been shown to activate the innate immune system in the respiratory tract and prevent viral and bacterial dissemination to the lungs.
Domain
enarespiratory.com
Country
AustraliaIndustry
BiotechnologyEmployees
1-10
Last Funding
$22.4M
Founded
2013
No technologies detected yet for this company.
Frequently Asked Questions
What technologies does Ena Respiratory use?+
We have not yet detected technologies for Ena Respiratory.
What industry is Ena Respiratory in?+
Ena Respiratory operates in the Biotechnology industry.
Where is Ena Respiratory based?+
Ena Respiratory is headquartered in Australia.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026